Literature DB >> 23205588

Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.

J Labus1, A Gupta, H K Gill, I Posserud, M Mayer, H Raeen, R Bolus, M Simren, B D Naliboff, E A Mayer.   

Abstract

BACKGROUND: Evidence supports the effectiveness of cognitive behavioural approaches in improving the symptoms of the irritable bowel syndrome (IBS). Duration, cost and resistance of many patients towards a psychological therapy have limited their acceptance. AIM: To evaluate the effectiveness of a psycho-educational intervention on IBS symptoms.
METHODS: Sixty-nine IBS patients (72% female) were randomised to an intervention or a wait-list control group. The IBS class consisted of education on a biological mind body disease model emphasising self-efficacy and practical relaxation techniques.
RESULTS: Patients in the intervention showed significant improvement on GI symptom severity, visceral sensitivity, depression and QoL postintervention and most of these gains were maintained at 3-month follow-up (Hedge's g = -0.46-0.77). Moderated mediation analyses indicated change in anxiety, visceral sensitivity, QoL and catastrophising due to the intervention had moderate mediation effects (Hedge's g = -0.38 to -0.60) on improvements in GI symptom severity for patients entering the trial with low to average QoL. Also, change in GI symptom severity due to the intervention had moderate mediation effects on improvements in QoL especially in patients with low to average levels of QoL at baseline. Moderated mediation analyses indicated mediation was less effective for patients entering the intervention with high QoL.
CONCLUSIONS: A brief psycho-educational group intervention is efficacious in changing cognitions and fears about the symptoms of the irritable bowel syndrome, and these changes are associated with clinically meaningful improvement in symptoms and quality of life. The intervention seems particularly tailored to patients with low to moderate quality of life baseline levels.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23205588      PMCID: PMC3829380          DOI: 10.1111/apt.12171

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  47 in total

1.  [Progressive muscle relaxation according to E. Jacobson. A modern relaxation technique].

Authors:  Franz Kohl
Journal:  Med Monatsschr Pharm       Date:  2002-03

Review 2.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

4.  Sleep disturbances in clinic patients with functional bowel disorders.

Authors:  R Fass; S Fullerton; S Tung; E A Mayer
Journal:  Am J Gastroenterol       Date:  2000-05       Impact factor: 10.864

5.  The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.

Authors:  I Heymann-Mönnikes; R Arnold; I Florin; C Herda; S Melfsen; H Mönnikes
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

Review 6.  Management of irritable bowel syndrome.

Authors:  Akira Torii; Gotaro Toda
Journal:  Intern Med       Date:  2004-05       Impact factor: 1.271

7.  Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome.

Authors:  Yuri A Saito; Charlene M Prather; Carol T Van Dyke; Sara Fett; Alan R Zinsmeister; G Richard Locke
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

8.  Self-management for women with irritable bowel syndrome.

Authors:  Margaret M Heitkemper; Monica E Jarrett; Rona L Levy; Kevin C Cain; Robert L Burr; Andrew Feld; Pam Barney; Pam Weisman
Journal:  Clin Gastroenterol Hepatol       Date:  2004-07       Impact factor: 11.382

9.  An irritable bowel syndrome-specific symptom questionnaire: development and validation.

Authors:  I K Wiklund; S Fullerton; C J Hawkey; R H Jones; G F Longstreth; E A Mayer; R A Peacock; I K Wilson; J Naesdal
Journal:  Scand J Gastroenterol       Date:  2003-09       Impact factor: 2.423

10.  Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics.

Authors:  C J Bijkerk; N J de Wit; J W M Muris; R H Jones; J A Knottnerus; A W Hoes
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

View more
  18 in total

Review 1.  Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.

Authors:  Jennifer S Labus; Catherine S Hubbard; Joshua Bueller; Bahar Ebrat; Kirsten Tillisch; Michelle Chen; Jean Stains; George E Dukes; Dennis L Kelleher; Bruce D Naliboff; Michael Fanselow; Emeran A Mayer
Journal:  Gastroenterology       Date:  2013-08-14       Impact factor: 22.682

2.  [A Meta-Analysis on the Effects of Mind-Body Therapy on Patients with Irritable Bowel Syndrome].

Authors:  Eun Hui Choi; Moon Ja Kim; Eun Nam Lee
Journal:  J Korean Acad Nurs       Date:  2020-06       Impact factor: 0.984

Review 3.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

Review 4.  Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Review.

Authors:  Xiaomei Cong; Mallory Perry; Katherine M Bernier; Erin E Young; Angela Starkweather
Journal:  West J Nurs Res       Date:  2017-08-30       Impact factor: 1.967

5.  Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.

Authors:  Ling Lan; Yu-Long Chen; Hao Zhang; Bai-Ling Jia; Yan-Jun Chu; Jin Wang; Shi-Xiao Tang; Guo-Dong Xia
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 6.  Brain-gut-microbiome interactions in obesity and food addiction.

Authors:  Arpana Gupta; Vadim Osadchiy; Emeran A Mayer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-27       Impact factor: 46.802

Review 7.  Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.

Authors:  Paul Moayyedi; Fermín Mearin; Fernando Azpiroz; Viola Andresen; Giovanni Barbara; Maura Corsetti; Anton Emmanuel; A Pali S Hungin; Peter Layer; Vincenzo Stanghellini; Peter Whorwell; Frank Zerbib; Jan Tack
Journal:  United European Gastroenterol J       Date:  2017-09-28       Impact factor: 4.623

Review 8.  Cognitive-behavioral therapy for the management of irritable bowel syndrome.

Authors:  Qing-Lin Tang; Guo-Yao Lin; Ming-Qing Zhang
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

9.  A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome.

Authors:  Kendra J Kamp; Anna M Plantinga; Kevin C Cain; Robert L Burr; Pamela Barney; Monica Jarrett; Ruth Ann Luna; Tor Savidge; Robert Shulman; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2021-01-08       Impact factor: 2.318

Review 10.  Psychological therapies in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Osama Altayar; Varun Sharma; Larry J Prokop; Amit Sood; Mohammad Hassan Murad
Journal:  Gastroenterol Res Pract       Date:  2015-01-31       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.